Vir Biotechnology

VIR · NASDAQ

$10.74+$0.53 (+5.19%)TodayMarket closed ·
Prev close $10.21

Who owns VIR

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 53.7% of VIR’s shares.

  • BlackRock Institutional Trust Company, N.A.10.9%
  • ARCH Venture Partners7.5%
  • Vanguard Portfolio Management, LLC6.8%
  • SB Investment Advisers (UK) Limited6.5%
  • Next 6 largest institutions22.0%
  • All other shareholders46.3%
Top institutional holders of VIR
HolderShares% of shares
BlackRock Institutional Trust Company, N.A.18.45M10.94%
ARCH Venture Partners12.69M7.53%
Vanguard Portfolio Management, LLC11.50M6.82%
SB Investment Advisers (UK) Limited10.95M6.49%
State Street Investment Management (US)9.96M5.91%
GSK plc8.55M5.07%
Vanguard Capital Management, LLC6.39M3.79%
Point72 Asset Management, L.P.5.67M3.36%
Geode Capital Management, L.L.C.3.35M1.99%
Dimensional Fund Advisors, L.P.3.12M1.85%

Largest mutual fund holders

Top mutual fund holders of VIR
HolderShares% of shares
iShares Core S&P Small-Cap ETF7.39M4.38%
State Street SPDR S&P Biotech ETF5.22M3.09%
Vanguard Total Stock Market Index Fund4.85M2.87%
Vanguard Small-Cap Index Fund3.49M2.07%
iShares Russell 2000 ETF3.14M1.86%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders sold $254.85K (3 trades) of VIR on the open market, with no buys.

Latest VIR insider transactions
InsiderTypeSharesValue
MORE ROBERT JOther8.00K—
MORE ROBERT JOther8.00K—
Coughlin TimothyAward16.00K—
Coughlin TimothyAward16.00K—
Coughlin TimothyAward8.00K—
Coughlin TimothyAward8.00K—
Napolitano JanetSale3.20K$30.24K
Sabatini BrentSale379$3.58K
Napolitano JanetAward16.00K—
Napolitano JanetAward8.00K—

Short interest

Settled Sep 30, 2026

Shares short
14.98M
Days to cover
7.01
% of shares outstanding
8.88%
Average daily volume
2.14M
Change since last report
−23.8%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.